Search Results 1451-1460 of 15403 for Hepatitis b

1. Cellular Immunotherapy In Recipients Of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

   Evidence of prior hepatitis B (HBV) infection as evaluated by hepatitis B surface antigen (HBsAg), total hepatitis B core antibody [(anti-HBc Immunoglobulin ...

2. A Study To Evaluate The Safety, Tolerability, And Determine The Optimal Dose For The Expansion Cohorts Of VSV-IFNβ-NIS In Combination With Pembrolizumab In Patients With Refractory Solid Tumors - Mayo Clinic

   Acute hepatitis B or acute hepatitis C (HCV). Patients with chronic hepatitis B or HCV may be enrolled provided their liver function is adequate as per ...

3. Liver biopsy - Doctors & Departments - Mayo Clinic

   There are no doctors whose last name begins with the letter B B ... Related. Acute liver failure · Alcoholic hepatitis (Alcohol-associated hepatitis) · Autoimmune ...

4. A Study To Assess Safety And Effectiveness Of Venetoclax In Combination With Gilteritinib In Subjects With Relapsed/Refractory Acute Myeloid Leukemia - Mayo Clinic

   ... hepatitis B, or hepatitis C. Note: HIV and hepatitis B or C testing is not required and subjects with serologic evidence of prior vaccination to hepatitis B ...

5. Daratumumab and hyaluronidase-fihj (subcutaneous route) - Side effects & uses - Mayo Clinic

   May make these conditions worse. Hepatitis B infection, active or history of or; Herpes zoster infection (shingles), history of—May reactivate these ...

6. And Compared With CIS And GEM Alone In HA-high Subjects With Previously Untreated, Unresectable, Locally Advanced, Or Metastatic Intrahepatic And Extrahepatic Cholangiocarcinoma And Gallbladder Adenocarcinoma - Mayo Clinic

   Active hepatitis B virus (HBV) infection, defined as having a positive hepatitis B surface antigen (HBsAg) test at screening. Active hepatitis C virus ...

7. Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine As First-Line Treatment For Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), Or Low-Blast Acute Myelogenous Leukemia (AML) - Mayo Clinic

   ... hepatitis B surface antigen and negative hepatitis B surface antibody) must have an undetectable hepatitis B viral load. Has known hepatic cirrhosis or ...

8. Maraviroc (oral route) - Side effects & dosage - Mayo Clinic

   Heart disease or; Liver problems (eg, hepatitis B or C), history of or · Kidney disease or; Liver disease—Use with caution. · Kidney disease, severe (may require ...

9. Ofatumumab As Primary Therapy Of Chronic Graft Versus Host Disease - Mayo Clinic

   Clinically active Hepatitis B defined as positive HBsAg; or positive HBcAb with detectable hepatitis B virus (HBV) DNA viral load. Patients who are HBcAb ...

10. cancer and luck Archives - Mayo Clinic News Network

    one of several hepatitis viruses, is generally considered to be the most serious. Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even ...